Proceedings: Chemotherapy and immunotherapy for cancer involving the skin.
D000287:Administration, Topical; D000942:Antigens, Bacterial; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000628:therapy*; D005069:Evaluation Studies as Topic; D005472:Fluorouracil / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007156:Immunologic Memory; D007167:Immunotherapy; D007642:Keratosis / Q000188:drug therapy; D011230:Precancerous Conditions; D012878:Skin Neoplasms / Q000188:drug therapy / Q000628:therapy*; D012882:Skin Tests
D000942:Antigens, Bacterial; D000970:Antineoplastic Agents; D005472:Fluorouracil